Invited commentary on "Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues" by Muntz

Affiliations

Comment

Elliott R Haut. Am J Surg. 2010 Sep.

. 2010 Sep;200(3):424-5.

doi: 10.1016/j.amjsurg.2009.09.031. Epub 2010 Apr 20.

¹ Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. ehaut1@jhmi.edu

No abstract available

Comment on

Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues.
Muntz J. Muntz J. Am J Surg. 2010 Sep;200(3):413-21. doi: 10.1016/j.amjsurg.2009.05.045. Epub 2010 Apr 20. Am J Surg. 2010. PMID: 20409525 Review.

Invited commentary on "Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues" by Muntz.
Clements RH. Clements RH. Am J Surg. 2010 Sep;200(3):422-3. doi: 10.1016/j.amjsurg.2009.10.021. Am J Surg. 2010. PMID: 20800719 No abstract available.
Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues.
Muntz J. Muntz J. Am J Surg. 2010 Sep;200(3):413-21. doi: 10.1016/j.amjsurg.2009.05.045. Epub 2010 Apr 20. Am J Surg. 2010. PMID: 20409525 Review.
[Venous thromboprophylaxis postcaesarean: survey of practices in Lorraine].
Vial F, Hein F, Boileau S, Vedel M, Bouaziz H. Vial F, et al. Ann Fr Anesth Reanim. 2009 Apr;28(4):395-6. doi: 10.1016/j.annfar.2009.02.008. Epub 2009 Mar 20. Ann Fr Anesth Reanim. 2009. PMID: 19303734 French. No abstract available.
The defined daily doses of low molecular weight heparins do not reflect current clinical practice.
Jorgensen LN, Gewert K. Jorgensen LN, et al. Acta Haematol. 2012;127(1):31-3. doi: 10.1159/000331005. Epub 2011 Oct 13. Acta Haematol. 2012. PMID: 21996727 No abstract available.
Deep vein thrombosis prophylaxis: friend or foe.
Rahman S. Rahman S. Am J Ther. 2009 Jul-Aug;16(4):300-3. doi: 10.1097/MJT.0b013e318183d549. Am J Ther. 2009. PMID: 19092638 Review.